切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2017, Vol. 06 ›› Issue (02) : 98 -101. doi: 10.3877/cma.j.issn.2095-3224.2017.02.003

所属专题: 文献

青年专家论坛

微生态制剂在结直肠外科围手术期的应用
沈通一1,(), 秦环龙1   
  1. 1. 200072 同济大学附属第十人民医院胃肠外科/同济大学医学院肠道疾病研究所
  • 收稿日期:2016-11-21 出版日期:2017-04-25
  • 通信作者: 沈通一

Application of microecological preparation in perioperative period of colorectal surgery

Tongyi Shen1,(), Huanlong Qin1   

  1. 1. Department of GI Surgery, Shanghai Tenth People′s Hospital Affiliated to Tongji University/Research Institute for Intestinal Diseases of Tongji University School of Medicine, Shanghai 200072, China
  • Received:2016-11-21 Published:2017-04-25
  • Corresponding author: Tongyi Shen
  • About author:
    Corresponding author: Shen Tongyi, Email:
引用本文:

沈通一, 秦环龙. 微生态制剂在结直肠外科围手术期的应用[J]. 中华结直肠疾病电子杂志, 2017, 06(02): 98-101.

Tongyi Shen, Huanlong Qin. Application of microecological preparation in perioperative period of colorectal surgery[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(02): 98-101.

结直肠癌患者围手术期使用微生态制剂已经越来越受到重视。目前认为微生态制剂具有改善肠道菌群,保护肠屏障,减少术后感染,改善围手术期胃肠功能及生活质量等作用,对疾病的治疗进程及预后具有重要意义。今后应该加强围手术期应用微生态制剂的临床研究,为进一步推广实施建立循证基础。

Perioperative use of microbial agents in colorectal cancer patients have been paid more and more attention recently. It is thought that microecological preparation has the functions of improving intestinal flora, protecting intestinal barrier, reducing postoperative infection, improving perioperative gastrointestinal function and quality of life, and is of great significance to the treatment process and prognosis. In the future, we should strengthen the clinical research of perioperative application of probiotics and establish the evidence-based basis for the further popularization and implementation of microecological preparations.

[1]
Peitsidou K, Karantanos T, Theodoropoulos GE. Probiotics, prebiotics, synbiotics: is there enough evidence to support their use in colorectal cancer surgery? [J]. Dig Surg, 2012, 29(5):426-438.
[2]
Thomas LV, Ockhuizen T. New insights into the impact of the intestinal microbiota on health and disease: a symposium report [J]. Br J Nutr, 2012, 107(Suppl 1):S1.
[3]
Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system [J]. JAMA Intern Med, 2013, 173(22):2039-2046.
[4]
Kinross JM, Markar S, Karthikesalingam A, et al. A meta-analysis of probiotic and synbiotic use in elective surgery: does nutrition modulation of the gut microbiome improve clinical outcome? [J]. JPEN J Parenter Enteral Nutr, 2013, 37(2):243-253.
[5]
Liu Z, Li C, Huang M, et al. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and doubleblind randomized clinical trial [J]. BMC Gastroenterol, 2015, 15(1):34.
[6]
Wu XD, Liu MM, Liang X, et al. Effects of perioperative supplementation with pro-/synbiotics on clinical outcomes in surgical patients: A meta-analysis with trial sequential analysis of randomized controlled trials [J]. ClinNutr, 2016, S0261-5614.
[7]
Arumugam S, Lau CS, Chamberlain RS. Probiotics and Synbiotics Decrease Postoperative Sepsis in Elective Gastrointestinal Surgical Patients: a Meta-Analysis [J]. J GastrointestSurg, 2016, 20(6):1123-1131.
[8]
Correia MI, Liboredo JC, Consoli ML. The role of probiotics in gastrointestinal surgery [J]. Nutrition, 2012, 28(3):230-234.
[9]
Ohigashi S, Sudo K, Kobayashi D, et al. Significant changes in the intestinal environment after surgery in patients with colorectal cancer [J]. J GastrointestSurg , 2013, 17(9):1657-1664.
[10]
Komatsu S, Sakamoto E, Norimizu S, et al. Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery: a randomized controlled trial [J]. Surg Today, 2016, 46(4):479-490.
[11]
Mizuta M, Endo I, Yamamoto S, et al. Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery, inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: a prospective, randomized clinical trial [J]. Biosci Microbiota Food Health, 2016, 35(2):77-87.
[12]
Sagar S, Morgan ME, Chen S, et al. Bifidobacteriumbreve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma [J]. Respir Res, 2014, 15:46.
[13]
Eguchi S, Takatsuki M, Hidaka M, et al. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study [J]. Am J Surg, 2011, 201(4):498-502.
[14]
Chen HQ, Yang J, Zhang M, et al. Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice [J]. Am J PhysiolGastrointest Liver Physiol, 2010, 299(6):G1287-1297.
[15]
Sommacal HM, Bersch VP, Vitola SP, et al. Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial [J]. Nutr Cancer, 2015, 67(3):457-462.
[16]
Reddy BS, Macfie J, Gatt M, et al. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy [J]. Br J Surg, 2007, 94(5):546-554.
[17]
Liu ZH, Huang MJ, Zhang XW, et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial [J]. Am J ClinNutr, 2013, 97(1):117-126.
[18]
Yang Y, Xia Y, Chen H, et al. The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial [J]. Oncotarget , 2016, 7(7):8432-8440.
[19]
Ohigashi S, Hoshino Y, Ohde S, et al. Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer [J]. Surg Today, 2011, 41(9):1200-1206.
[20]
Pellino G, Sciaudone G, Candilio G, et al.Early postoperative administration of probiotics versus placebo in elderly patients undergoing elective colorectal surgery: a double-blind randomized controlled trial [J]. BMC Surg, 2013, 13(Suppl 2):S57.
[21]
Van den Nieuwboer M, Claassen E, Morelli L, et al. Probiotic and synbiotic safety in infants under two years of age [J]. Benef Microbes, 2014, 5(1):45-60.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 董红华, 郭艮春, 江磊, 吴雪飞, 马飞翔, 李海凤. 骨科康复一体化模式在踝关节骨折快速康复中的应用[J]. 中华关节外科杂志(电子版), 2023, 17(06): 802-807.
[3] 李辉, 吴奇, 张子琦, 张晗, 王仿, 许鹏. 日间全膝关节置换术早期疗效及标准化流程探索[J]. 中华关节外科杂志(电子版), 2023, 17(06): 889-892.
[4] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[5] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[6] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[7] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[8] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[9] 夏松, 姚嗣会, 汪勇刚. 经腹腹膜前与疝环充填式疝修补术治疗腹股沟疝的对照研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 702-705.
[10] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[11] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[12] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[13] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[14] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[15] 程相阵. 腹茧症9例诊治分析并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(9): 968-971.
阅读次数
全文


摘要